Evidence map›Paper›PMID 30337366›Full record

ArticleThe Journal of biological chemistry2018

Transcription factor Sp2 potentiates binding of the TALE homeoproteins Pbx1:Prep1 and the histone-fold domain protein Nf-y to composite genomic sites.

Sara Völkel, Bastian Stielow, Florian Finkernagel, Dana Berger, Thorsten Stiewe, Andrea Nist, Guntram Suske

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. NFS1 Regulates IDH2 to Attenuate Abdominal Aortic Aneurysms via Interacting With SP2.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. The role(s) of NF-Y in development and differentiation.Cell death and differentiation · 2025
    Review
  4. Article
  5. On the NF-Y regulome as in ENCODE (2019).PLoS computational biology · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 3 countries.

Sara VölkelFrom the Institute of Molecular Biology and Tumor Research (IMT) and.
Bastian StielowFrom the Institute of Molecular Biology and Tumor Research (IMT) and.
Florian FinkernagelFrom the Institute of Molecular Biology and Tumor Research (IMT) and.
Dana BergerFrom the Institute of Molecular Biology and Tumor Research (IMT) and.
Thorsten Stiewethe Genomics Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps-University of Marburg, 35043 Marburg, Germany.
Andrea Nistthe Genomics Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps-University of Marburg, 35043 Marburg, Germany.
Guntram SuskeFrom the Institute of Molecular Biology and Tumor Research (IMT) and Suske@imt.uni-marburg.de.ORCID 0000-0002-4807-0513
Philipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different transcription factors operate together at promoters and enhancers to regulate gene expression. Transcription factors either bind directly to their target DNA or are tethered to it by other proteins. The transcription factor Sp2 serves as a paradigm for indirect genomic binding. It does not require its DNA-binding domain for genomic DNA binding and occupies target promoters independently of whether they contain a cognate DNA-binding motif. Hence, Sp2 is strikingly different from its closely related paralogs Sp1 and Sp3, but how Sp2 recognizes its targets is unknown. Here, we sought to gain more detailed insights into the genomic targeting mechanism of Sp2. ChIP-exo sequencing in mouse embryonic fibroblasts revealed genomic binding of Sp2 to a composite motif where a recognition sequence for TALE homeoproteins and a recognition sequence for the trimeric histone-fold domain protein nuclear transcription factor Y (Nf-y) are separated by 11 bp. We identified a complex consisting of the TALE homeobox protein Prep1, its partner PBX homeobox 1 (Pbx1), and Nf-y as the major partners in Sp2-promoter interactions. We found that the Pbx1:Prep1 complex together with Nf-y recruits Sp2 to co-occupied regulatory elements. In turn, Sp2 potentiates binding of Pbx1:Prep1 and Nf-y. We also found that the Sp-box, a short sequence motif close to the Sp2 N terminus, is crucial for Sp2's cofactor function. Our findings reveal a mechanism by which the DNA binding-independent activity of Sp2 potentiates genomic loading of Pbx1:Prep1 and Nf-y to composite motifs present in many promoters of highly expressed genes.

Indexed as

GenomicsAnimalsCCAAT-Binding FactorCell LineHistonesHomeodomain ProteinsMiceNucleotide MotifsPre-B-Cell Leukemia Transcription Factor 1Protein BindingProtein TransportSp2 Transcription FactorZinc FingersCCAAT-Binding FactorHistonesHomeodomain ProteinsPknox1 protein, mousePre-B-Cell Leukemia Transcription Factor 1Sp2 Transcription Factorchromatin immunoprecipitation (ChiP)gene regulationnuclear factor y (Nf-y)Pbx1Prep1specificity protein 1 (Sp1)TALE homeoproteinstranscription factortranscription factor Sp2transcription target gene

Identifiers

PMID30337366
PMCPMC6302174
OpenAlexW2896927938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.